ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

eltrombopag

Also written as “Eltrombopag”, “SB497115” and “Eltrombopag olamine”.

Its studies are mostly in Purpura, Thrombocytopenic, Idiopathic · Thrombocytopenia · Anemia, Aplastic · Purpura · Hepatitis C, Chronic, led by 4 companies.

Drug pageEltrombopag: every studyAll 135 studies of it, academic ones too, with its approvals, label and forms.
Furthest: phase 4, since Jan 7, 201049 company-led studies, 3 open or runningNext primary completion: Apr 22, 2033 (phase 2)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
GlaxoSmithKline290 open or runningphase 4since Jan 7, 2010Feb 1, 2005none ahead
Novartisits history only182 open or runningphase 4since Oct 4, 2013Jul 10, 2006Apr 22, 2033phase 2 · NCT07660172
Bristol-Myers Squibbits history only10 open or runningphase 1since Jun 20, 2023Jun 20, 2023none ahead
Renataits history only11 open or runningphase 2since Jul 6, 2024Jul 6, 2024none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of GlaxoSmithKline only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 15 studies since Feb 1, 2005.

  1. Jan 29, 2009Phase 1 study in Hepatitis CNCT00833378 · 40 enrolled · United States
  2. Mar 5, 2009Phase 2 study in Liver DiseasesNCT00861601 · 38 enrolled · Japan
  3. May 14, 2009Phase 1 study in Myelodysplastic SyndromesNCT00903422 · 98 enrolled · United States, Brazil, Denmark and more
  4. May 21, 2009Phase 2 study in PurpuraNCT00908037 · 82 enrolled · United States, Canada, France and more
  5. Oct 1, 2009Phase 3 study in Hepatitis CNCT00996216 · 27 enrolled · United States, Australia, Canada and more
  6. Jan 7, 2010Phase 4 study in ThrombocytopeniaNCT01055600 · United States
  7. Feb 12, 2010Phase 1 study in PurpuraNCT01072162 · 40 enrolled · United States
  8. Mar 25, 2010Phase 4 study in PurpuraNCT01098487 · 167 enrolled · United States, Czech Republic, France and more
  9. May 20, 2010Phase 2 study in ThrombocytopeniaNCT01147809 · 130 enrolled · United States, Belgium, Canada and more
  10. Dec 21, 2011Phase 3 study in Purpura, Thrombocytopenic, IdiopathicNCT01520909 · 92 enrolled · United States, Argentina, Czech Republic and more
  11. Jul 5, 2012Phase 2 study in Hepatitis C, ChronicNCT01636778 · 45 enrolled · Japan
  12. Aug 2, 2012Phase 1 study in ThrombocytopeniaNCT01657552 · 56 enrolled · United States
  13. Sep 29, 2014Phase 1 study in Liver CirrhosisNCT02254434 · 26 enrolled · Mexico
  14. Oct 30, 2014Phase 1 study in Purpura, Thrombocytopenic, IdiopathicNCT02281370 · 39 enrolled · United States

TargetBeta

MPL →read by rule
“Thrombopoietin receptor agonist; Thrombopoietin receptor agonist”ChEMBL 37, by rule

Other programs on MPL

ProgramCompanyFurthest phaseStudies
romiplostimruleAmgenphase 438
avatrombopagruleEisaiphase 425
hetrombopag olamineruleJiangsu HengRui Medicinephase 315

Studies

All 29 GlaxoSmithKline leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT02281370Purpura, Thrombocytopenic, Idiopathic · United States1CompletedDec 24, 201439
NCT02254434Liver Cirrhosis · Mexico1CompletedSep 8, 201426
NCT01657552Thrombocytopenia · United States1CompletedOct 26, 201256
NCT01636778Hepatitis C, Chronic · Japan2CompletedMay 201445
NCT01520909Purpura, Thrombocytopenic, Idiopathic · United States, Argentina, Czech Republic and more3CompletedJan 201492
NCT01147809Thrombocytopenia · United States, Belgium, Canada and more2CompletedJan 2015130
NCT01098487Purpura · United States, Czech Republic, France and more4CompletedMay 2014167
NCT01072162Purpura · United States1CompletedApr 7, 201040
NCT01055600Thrombocytopenia · United States4WithdrawnJul 20140
NCT00996216Hepatitis C · United States, Australia, Canada and more3CompletedFeb 201327
NCT00908037Purpura · United States, Canada, France and more2CompletedFeb 1, 201482
NCT00903422Myelodysplastic Syndromes · United States, Brazil, Denmark and more1CompletedJun 26, 201298
NCT00861601Liver Diseases · Japan2CompletedAug 200938
NCT00833378Hepatitis C · United States1CompletedMar 11, 200940
NCT00828750Purpura, Thrombocytopenic, Idiopathic · Japan3CompletedFeb 201119
NCT00688272Purpura · United Kingdom1CompletedSep 25, 200836
NCT00678587Non-alcoholic Fatty Liver Disease · United States, Argentina, Belgium and more3TerminatedOct 2009292
NCT00540423Purpura, Thrombocytopenic, Idiopathic · Japan3CompletedDec 200823
NCT00529568Hepatitis C, Chronic · United States, Australia, Belgium and more3CompletedAug 2011759
NCT00516321Hepatitis C, Chronic · United States, Australia, Belgium and more3CompletedApr 2011687
NCT00487968Purpura, Thrombocytopenic, Idiopathic · United States1Completed12
NCT00442871Purpura · United States1CompletedJan 3, 200829
NCT00424177Purpura · Germany, Russian Federation2CompletedAug 200866
NCT00370331Purpura · United States, Austria, Canada and more3CompletedJul 2008197
NCT00359463Purpura · United States, Australia, New Zealand1CompletedMar 7, 200733
NCT00358540Thrombocytopenia · United States1CompletedOct 22, 201018
NCT00110799Hepatitis C, Chronic · United States, France, Germany and more2CompletedOct 200675
NCT00102739Purpura · Germany, Greece, Hong Kong and more2CompletedJan 200799
NCT00102726Thrombocytopenia · United States, Argentina, Austria and more2CompletedFeb 2007183

How it is read

Names in the registry

  • “Eltrombopag”, 19 entries
  • “eltrombopag”, 15 entries
  • “SB497115”, 3 entries
  • “Eltrombopag olamine”, 2 entries
  • “Eltrombopag 25 MG”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.